Report Scope:
The scope of this study involves the global market of cancer vaccines. The report covers the entire market of cancer vaccines, which includes two main areas of application, prophylactic vaccines and therapeutic vaccines. Discussion of human papillomavirus vaccines and hepatitis B vaccines that indirectly act against cancer is also included in the report.

Based on application, the market covers various cancer types such as prostate, liver, cervical, lung and bladder. Both marketing and research and development (R&D) perspectives are discussed in the report.

By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data have been provided for the year 2020 as the base year, with forecasts for 2021 through 2026.

Patent analysis, clinical trials, innovative research and opportunities of the newest trends within the cancer vaccine market and comprehensive profiles of companies that lead the cancer vaccine industry are also discussed.

Report Includes:

  • 20 data tables and 23 additional tables
  • An overview of the global markets and technologies for cancer vaccines
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Detailed description of history, management, and causes of cancer including genetic factors, lifestyle factors and environmental factors, and information on types of cancer-causing genes
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and an overview of current and future dynamics of the global market for various cancer vaccines
  • Discussion on present and future strategies within the cancer vaccines market, and comparative assessment of prophylactic vaccines and therapeutic vaccines
  • Coverage of approved cancer vaccines, recalls, fast track designations and orphan drug designation and analysis of pipeline products and patents
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Comprehensive company profiles of the leading players of the industry, including Amgen Inc., Dendreon Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc. and Vaccinogen Inc.